SLCH Consortium Neuromuscular Medicine (Neurology)

Topics

• Amyotrophic Lateral Sclerosis Research 254
• Muscle Physiology and Disorders 180
• Myasthenia Gravis and Thymoma 116
• Peripheral Neuropathies and Disorders 102
• Inflammatory Myopathies and Dermatomyositis 93
• Neurogenetic and Muscular Disorders Research 56
• Genetic Neurodegenerative Diseases 48
• Hereditary Neurological Disorders 38
• Lysosomal Storage Disorders Research 34
• Mitochondrial Function and Pathology 33
• Ion channel regulation and function 32
• Cardiomyopathy and Myosin Studies 29

Most cited

1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1.

   Autophagy · 2021 · 2,291 citations · Conrad Weihl

2. Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS.

   The New England journal of medicine · 2022 · 755 citations · Timothy Miller, Robert Bucelli

3. AAV gene therapy for Duchenne muscular dystrophy: the EMBARK phase 3 randomized trial.

   Nature medicine · 2025 · 143 citations · Craig Zaidman

4. Skin Biopsy Detection of Phosphorylated α-Synuclein in Patients With Synucleinopathies.

   JAMA · 2024 · 170 citations · Todd Levine

5. Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study.

   The Lancet. Neurology · 2023 · 218 citations · Yessar Hussain

6. Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial.

   The Lancet. Neurology · 2021 · 399 citations ·